RxDoctor Payments Data

Kerry Corcoran

Acute Care · Stamford, CTNPI 1821860412

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,852, more than ten times the $165 reported in 2023. Among acute care clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,171in general payments, 2019–2025

Across 140 payments — averaging $22.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$405
  • E.r. Squibb & Sons, L.L.C.$366
  • Novo Nordisk$341
  • Amgen$310
  • Esperion Therapeutics, Inc.$255
  • Alnylam Pharmaceuticals Inc.$244
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,171100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,171 in reported general payments places this provider in the 90th percentile of 239 acute care providers in Connecticut.

See all acute care providers in Connecticut

Other acute care in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →